摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-嘧啶羧酸,1,4-二氢-6-甲基-2-(甲硫基)-4-(3-硝基苯基)-,2-[甲基(苯基甲基)氨基]乙基酯 | 125734-93-2

中文名称
5-嘧啶羧酸,1,4-二氢-6-甲基-2-(甲硫基)-4-(3-硝基苯基)-,2-[甲基(苯基甲基)氨基]乙基酯
中文别名
——
英文名称
2-[Benzyl(methyl)amino]ethyl 6-methyl-2-methylsulfanyl-4-(3-nitrophenyl)-1,4-dihydropyrimidine-5-carboxylate
英文别名
2-[benzyl(methyl)amino]ethyl 6-methyl-2-methylsulfanyl-4-(3-nitrophenyl)-1,4-dihydropyrimidine-5-carboxylate
5-嘧啶羧酸,1,4-二氢-6-甲基-2-(甲硫基)-4-(3-硝基苯基)-,2-[甲基(苯基甲基)氨基]乙基酯化学式
CAS
125734-93-2
化学式
C23H26N4O4S
mdl
——
分子量
454.55
InChiKey
ZJYQKNJYKBJZMV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    586.1±60.0 °C(Predicted)
  • 密度:
    1.26±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    32
  • 可旋转键数:
    9
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    125
  • 氢给体数:
    1
  • 氢受体数:
    7

反应信息

  • 作为产物:
    描述:
    2-[(3-nitrophenyl)methylene]-3-oxobutanoic acid, 2-[methyl(phenylmethyl)amino]ethyl ester 、 2-甲基-2-疏基硫酸脲sodium acetate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 5-嘧啶羧酸,1,4-二氢-6-甲基-2-(甲硫基)-4-(3-硝基苯基)-,2-[甲基(苯基甲基)氨基]乙基酯
    参考文献:
    名称:
    Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines
    摘要:
    2-Heterosubstituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecar box ylic acid esters 8, which lack the potential CS symmetry of dihydropyridine calcium channel blockers, were prepared and evaluated for biological activity. Biological assays using potassium-depolarized rabbit aorta and radioligand binding techniques showed that some of these compounds are potent mimics of dihydropyridine calcium channel blockers. The combination of a branched ester (e.g. isopropyl, sec-butyl) and an alkylthio group (e.g. SMe) was found to be optimal for biological activity. When compared directly with similarly substituted 2-heteroalkyldihydropyridines 9, dihydropyrimidines 8 were found to be 30-fold less active. The solid-state structure of dihydropyrimidine analogue 8g shows that these compounds can adopt a molecular conformation which is similar to the reported conformation of dihydropyridine calcium channel blockers.
    DOI:
    10.1021/jm00167a035
点击查看最新优质反应信息